Early palliative care for head and neck cancer
Part of Cancer clinical trials.
This trial tests whether adding early palliative care to standard chemoradiation helps people with advanced head and neck cancer feel better and live better. It aims to improve quality of life during and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of head and neck cancer (in the mouth, throat, voice box, or lower throat) that cannot be removed with surgery.
- You are 18 years or older.
- You are well enough to be up and about (able to care for yourself, but may not be able to do heavy work).
- Your blood counts and liver and kidney function are within acceptable levels.
- You have not had specialized palliative care before, and you are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding early palliative care from a specialist improves well-being for people starting treatment for advanced non-small cell lung cancer. It compares standard cancer care alone to standard care plus early palliative care.
This study tests whether having a palliative care specialist meet with patients early during an unplanned hospital stay improves their care and quality of life. Palliative care focuses on comfort and symptom management, and this trial aims to see if adding it to usual treatment helps.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial tests a custom treatment plan for people with advanced head and neck cancer that is not caused by HPV. It combines radiation and chemotherapy with a targeted drug called cetuximab, adjusted based on your tumor's characteristics.
This trial tests a navigation program (help from a care coordinator) versus usual care to help people start the recommended “next-step” treatments (like radiation, sometimes with chemo) on time after surgery. It’s for certain stages of squamous cell cancer in the head and neck area where late treatment could matter.
Hear when a new Locally Advanced Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.